Florian Franz

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 7

Top Topics

Colorectal Cancer Screening

Simultaneous Determination

Loop Mediated Isothermal Amplification

Ultra High Performance Liquid Chromatography

Top Venues

Drug testing and analysis

Clinical toxicology (Philadelphia, Pa.)

This page only lists publications with an associated author ORCID identifier.

Publications

Verena Angerer, Yasmin Schmid, Florian Franz, Heike Gnann, Jan Manuel Speer, Anke Gnann, Stephan Helmecke, Armin Buchwald, Simon D Brandt, Torsten Passie, Matthias E Liechti, Volker Auwärter
Acute psychotropic, autonomic, and endocrine effects of 5,6-methylenedioxy-2-aminoindane (MDAI) compared with 3,4-methylenedioxymethamphetamine (MDMA) in human volunteers: A self-administration study. Drug testing and analysis (2023)
Florian Franz, Belal Haschimi, Leslie A King, Volker Auwärter
Extraordinary long detection window of a synthetic cannabinoid metabolite in human urine - Potential impact on therapeutic decisions. Drug testing and analysis 12 (3) (2020)
Arianna Giorgetti, Lukas Mogler, Belal Haschimi, Sebastian Halter, Florian Franz, Folker Westphal, Svenja Fischmann, Jan Riedel, Michael Pütz, Volker Auwärter
Detection and phase I metabolism of the 7-azaindole-derived synthetic cannabinoid 5F-AB-P7AICA including a preliminary pharmacokinetic evaluation. Drug testing and analysis 12 (1) (2019)
Lukas Mogler, Maurice Wilde, Laura M Huppertz, Georg Weinfurtner, Florian Franz, Volker Auwärter
Phase I metabolism of the recently emerged synthetic cannabinoid CUMYL-PEGACLONE and detection in human urine samples. Drug testing and analysis 10 (5) (2018)
Lukas Mogler, Florian Franz, Maurice Wilde, Laura M Huppertz, Sebastian Halter, Verena Angerer, Bjoern Moosmann, Volker Auwärter
Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples. Drug testing and analysis 10 (9) (2018)
Lukas Mogler, Florian Franz, Daniel Rentsch, Verena Angerer, Georg Weinfurtner, Mitchell Longworth, Samuel D Banister, Michael Kassiou, Bjoern Moosmann, Volker Auwärter
Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples. Drug testing and analysis 10 (1) (2017)
Maren Hermanns-Clausen, Dieter Müller, Josephine Kithinji, Verena Angerer, Florian Franz, Florian Eyer, Hartmud Neurath, Gesine Liebetrau, Volker Auwärter
Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA. Clinical toxicology (Philadelphia, Pa.) 56 (6) (2017)